Patent ID: 7893096

Claim:
A pharmaceutical vaccine composition comprising a benzazole compound adjuvant and an antigen, wherein said benzazole compound adjuvant is present in an amount effective to enhance the immune response in a subject to the antigen, and wherein the benzazole compound is of formula (XXI): wherein A is —O—; W is selected from the group consisting of —CH 2 —, —O—, —S—, —NH—, and —NR 8 —; R 7 is selected from the group consisting of carbocyclyl, unfused carbocyclylcarbocyclyl, substituted aryl, unsubstituted aryl, substituted heteroaryl, unsubstituted heteroaryl, substituted fused arylheteroaryl, unsubstituted fused arylheteroaryl, substituted unfused arylaryl and unsubstituted unfused arylaryl; R 6 is selected from the group consisting of substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; and, R 8 is independently substituted or unsubstituted alkyl, or a pharmaceutically acceptable salt, ester, or prodrug thereof.